ZA201008223B - Processes for the synthesis of levocetirizine and intermediates for use therein - Google Patents

Processes for the synthesis of levocetirizine and intermediates for use therein

Info

Publication number
ZA201008223B
ZA201008223B ZA2010/08223A ZA201008223A ZA201008223B ZA 201008223 B ZA201008223 B ZA 201008223B ZA 2010/08223 A ZA2010/08223 A ZA 2010/08223A ZA 201008223 A ZA201008223 A ZA 201008223A ZA 201008223 B ZA201008223 B ZA 201008223B
Authority
ZA
South Africa
Prior art keywords
levocetirizine
intermediates
synthesis
processes
Prior art date
Application number
ZA2010/08223A
Other languages
English (en)
Inventor
Dharmaraj Ramachandra Rao
Rajendra Narayanrao Kankan
Maruti Ghagare
Sandip Vasant Chikhalikar
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of ZA201008223B publication Critical patent/ZA201008223B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/58—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA2010/08223A 2008-06-02 2010-11-17 Processes for the synthesis of levocetirizine and intermediates for use therein ZA201008223B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1173MU2008 2008-06-02

Publications (1)

Publication Number Publication Date
ZA201008223B true ZA201008223B (en) 2011-08-31

Family

ID=41009315

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2010/08223A ZA201008223B (en) 2008-06-02 2010-11-17 Processes for the synthesis of levocetirizine and intermediates for use therein

Country Status (10)

Country Link
US (1) US8350031B2 (enExample)
EP (1) EP2307392A2 (enExample)
JP (1) JP2011523659A (enExample)
KR (1) KR20110022635A (enExample)
CN (1) CN102046612A (enExample)
AU (1) AU2009254959B2 (enExample)
CA (1) CA2724887A1 (enExample)
NZ (1) NZ589492A (enExample)
WO (1) WO2009147389A2 (enExample)
ZA (1) ZA201008223B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2307392A2 (en) 2008-06-02 2011-04-13 Cipla Limited Processes for the synthesis of levocetirizine and intermediates for use therein
CN103044356A (zh) * 2011-10-13 2013-04-17 湖南九典制药有限公司 合成左西替利嗪的新方法及其关键中间体
CN110988163B (zh) * 2019-11-29 2022-04-19 重庆华邦胜凯制药有限公司 一种hplc法分离测定盐酸左西替利嗪及其基因毒性杂质e的方法
CN111205247B (zh) * 2020-04-22 2020-08-14 湖南九典宏阳制药有限公司 左旋西替利嗪的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2792398A (en) * 1954-12-03 1957-05-14 Miles Lab Piperazine derivatives
US3790606A (en) * 1970-09-30 1974-02-05 Diamond Shamrock Corp Alkoxylated mannich compositions and derivatives thereof
NL7306771A (enExample) * 1972-06-02 1973-12-04
FI75816C (fi) 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
US4656182A (en) 1983-12-06 1987-04-07 Warner-Lambert Company Substituted trans-1,2-diaminocyclohexyl amide compounds
GB8827391D0 (en) 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
GB9305282D0 (en) * 1993-03-15 1993-05-05 Ucb Sa Enantiomers of 1-(4-chlorophenyl)phenylmethyl)-4-(4-methylphenyl)sulphonyl)piperazine
JP4416198B2 (ja) * 1997-12-19 2010-02-17 武田薬品工業株式会社 アニリド誘導体、その製造法および用途
WO2000044723A1 (en) * 1999-01-27 2000-08-03 American Cyanamid Company Alkynyl containing hydroxamic acid derivatives, their preparation and their use as matrix metalloproteinase (mmp) inhibitors/tnf-alpha converting enzyme (tace) inhibitors
AR035312A1 (es) * 1999-01-27 2004-05-12 Wyeth Corp Compuestos de acido hidroxamico que contienen alquinilo como inhibidores de metaloproteinasa de matriz/tace, composicion farmaceutica que los comprenden y el uso de los mismos para la manufactura de un medicamento
US6762180B1 (en) * 1999-10-13 2004-07-13 Boehringer Ingelheim Pharma Kg Substituted indolines which inhibit receptor tyrosine kinases
JP4044740B2 (ja) * 2001-05-31 2008-02-06 信越化学工業株式会社 レジスト材料及びパターン形成方法
HU227074B1 (en) * 2005-12-08 2010-06-28 Egis Gyogyszergyar Nyrt An optically active carbamic acid derivative, method for producing the same and use as a pharmaceutical intermediate
EP2307392A2 (en) 2008-06-02 2011-04-13 Cipla Limited Processes for the synthesis of levocetirizine and intermediates for use therein

Also Published As

Publication number Publication date
WO2009147389A2 (en) 2009-12-10
WO2009147389A3 (en) 2010-07-01
WO2009147389A8 (en) 2010-12-23
EP2307392A2 (en) 2011-04-13
CA2724887A1 (en) 2009-12-10
AU2009254959A1 (en) 2009-12-10
AU2009254959A8 (en) 2011-01-20
US8350031B2 (en) 2013-01-08
JP2011523659A (ja) 2011-08-18
NZ589492A (en) 2012-06-29
US20110184174A1 (en) 2011-07-28
KR20110022635A (ko) 2011-03-07
AU2009254959B2 (en) 2014-01-30
CN102046612A (zh) 2011-05-04

Similar Documents

Publication Publication Date Title
IL202664A (en) Processes for Preparation of 3-Dihlomethyl-1-Methyl-1H-Pyrazole-4-Carbaldehyde and Intermediates
SI3329775T1 (sl) Procesi za sintezo spojin diariltiohidantoina in diarilhidantoina
PL2954932T3 (pl) Zastosowanie terapeutyczne diaminofenotiazyn
EP2464227A4 (en) COMPOUNDS AND METHODS OF USE
AP2009004935A0 (en) New process for the synthesis of agomelatine
AP3167A (en) New process for the synthesis of agomelatine
PL2328545T3 (pl) Zastosowanie glukozyloglicerolu
ZA201200894B (en) Synthesis and use of zsm-12
IL216650A0 (en) Process for the preparation and purification of etravirine and intermediates thereof
IL223066A (en) A process for taptadol synthesis and its intermediates
SI2189442T1 (sl) Postopek in intermediati za pripravo aliskirena
EP2576556A4 (en) PROCESS FOR SYNTHESIZING CARBONUCLEOSIDE AND PARTICIPATING INTERMEDIATES
AP2509A (en) New process for the synthesis of agomelatine
ZA201008223B (en) Processes for the synthesis of levocetirizine and intermediates for use therein
GB2459413A8 (en) Perfluoroparacyclophane and methods of synthesis and use thereof
EG27000A (en) Process for the preparation of ibodutant (MEN15596) and related intermediates
HU0900712D0 (en) New methods and intermediers for the synthesis of ace-inhibitor
PL384700A1 (pl) Sposób syntezy 1-propenyloksyalkoholu
HU0800656D0 (en) Effective use of tea-composition
PL383760A1 (pl) Nowe zastosowanie undekan-2-olu
PL383758A1 (pl) Nowe zastosowanie undekan-2-onu
PL383759A1 (pl) Nowe zastosowanie undekan-2-olu